Korean Intellectual Property Office Releases Allergan's Patent Application for 2,5-Dioxoimidazolidin...
Korean Intellectual Property Office Releases Allergan's Patent Application for 2,5-Dioxoimidazolidin-1-Yl-3-Phenylurea Derivatives as Formyl Peptide Receptor Like-1 (FPRL-1) Receptor Modulators
About this item
Full title
Korean Intellectual Property Office Releases Allergan's Patent Application for 2,5-Dioxoimidazolidin-1-Yl-3-Phenylurea Derivatives as Formyl Peptide Receptor Like-1 (FPRL-1) Receptor Modulators
Publisher
New Delhi: Pedia Content Solutions Pvt. Ltd
Journal title
Global IP News. Pharmaceutical Patent News, 2015
Language
English
Formats
Publication information
Publisher
New Delhi: Pedia Content Solutions Pvt. Ltd
More information
Alternative Titles
Full title
Korean Intellectual Property Office Releases Allergan's Patent Application for 2,5-Dioxoimidazolidin-1-Yl-3-Phenylurea Derivatives as Formyl Peptide Receptor Like-1 (FPRL-1) Receptor Modulators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1672892129
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1672892129
How to access this item
Log in as a Library member
